Meina Wang

Meina Wang is a Research Scientist at Yale School of Medicine and Director for Education and Translational Research in Medical Oncology and Hematology. She also serves as Associate Program Director for the Master of Health Science in Clinical Investigation (MHS-CI) program.

• Yale School of Medicine, Department of Medical Oncology and Hematology
• Internal Medicine Department affiliation
• Co-leads translational research initiatives in cancer and bone biology

Research Focus: Meina Wang specializes in clinical cancer research, bone remodeling mechanisms, and translational approaches to lung cancer treatment. Her work bridges immunotherapy strategies, surgical oncology, and skeletal biology with particular emphasis on TGFβ signaling, PTHrP pathways, and TMJ development.

• Developing personalized therapies for non-small cell lung cancer
• Investigating bone adaptation during reproduction and healing
• Exploring immunomodulatory agents in oncology

Scientific Recognition:

• New Investigator Award (Orthopaedics Research Society, 2012)
• Young Investigator Awards (ASBMR, 2009-2012)
• Harold M. Frost Young Investigator Award (2012)

Collaborative Network: Partners with leading researchers including Dr. Roy Herbst (Yale Cancer Center) and Dr. Harriet Kluger. Active on editorial boards since 2011 and contributes to key journals in oncology and skeletal biology.